Evolution of health burden and life expectancy under different expenditure scenarios. by Margherita Molaro (17803989)

Scaling of overall health burden with yearly expenditure growth. by Margherita Molaro (17803989)

Impact on different areas of health. by Margherita Molaro (17803989)

ENP C-term phosphomimic variants and <i>enp</i> rescue. by Michaela S. Matthes (21587677)

Sociodemographic Characteristics of Sample 2. by Aistė Ambrasė (22505574)

“…We also found that the mean agreement with the IB-DE subscale decreased after the pandemic. …”

English and German versions of OUS. by Aistė Ambrasė (22505574)

“…We also found that the mean agreement with the IB-DE subscale decreased after the pandemic. …”

Raw database. by Franco Romaní-Romaní (21989788)

“…</p><p>Results</p><p>We included 1,899 test scores from 669 medical students. The mean score across all tests was 9.19 (standard deviation = 2.34). …”

Ingenuity pathway analysis of tonic ISG subclasses. by Tyron Chang (9922533)

qPCR of vaccinia virus RNAs <i>IRF1</i> KO cells: glucose with and without IFN-γ priming. by Tyron Chang (9922533)

Analysis of host and interferon-induced responses in glucose/galactose infected with vaccinia virus. by Tyron Chang (9922533)

Glucose/galactose with extended interferon-priming does not impact levels of ISG RNAs or non-ISG proteins levels. by Tyron Chang (9922533)

Time course of IRF1 and IFITM3 RNA and protein expression across conditions. by Tyron Chang (9922533)

Vaccinia virus and VSV infections of <i>STAT1</i> and <i>IRF1</i> KO cells grown in glucose/galactose with and without IFN-γ priming. by Tyron Chang (9922533)

Vaccinia virus infection (MOI = 3) of A549 cells in media supplemented with glucose/galactose. by Tyron Chang (9922533)

Glucose/galactose regulation of IFN-γ induced IRF1 protein is conserved in mammals. by Tyron Chang (9922533)

Characterization of the impact of glucose/galactose on infection outcomes. by Tyron Chang (9922533)

Glucose/galactose selectively alters ISG protein not RNA levels in interferon-primed cells. by Tyron Chang (9922533)

Glucose but not galactose culturing of IFN-γ primed cells reduces VACV and HSV-1 replication. by Tyron Chang (9922533)

<i>IRF1</i> impacts VACV replication in glucose/IFN-γ primed but not galactose conditions. by Tyron Chang (9922533)

Effects of bortezomib/venetoclax on the growth suppression of sLCL 381 xenografts in SCID mice. by Kam Pui Tam (19746865)